MarketPeel
Insider Trading Intelligence
AB

Amos Bar-shalev

PLX
DIRECTOR · PROTALIX BIOTHERAPEUTICS, INC. · CIK 0001385113
FILING MIX · LIFETIME83%/17%
BUYS
5
SELLS
1
TOTAL VALUE
$314
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
0
AVG SELL PX
$1.87
TRADE KIND
SHOWING 6 / 6
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Amos Bar-shalev, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-4.79%+2.26%-7.05%-7.05%
14d1+100.00%-11.17%+3.25%-14.42%-14.42%
30d1+100.00%-4.25%+2.48%-6.74%-6.74%
60d1+0.00%+8.51%+4.78%+3.73%+3.73%
90d1+0.00%+58.51%+3.45%+55.06%+55.06%
180d1+0.00%+6.12%+12.46%-6.34%-6.34%
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PLX · 0 shares · as of Nov 18, 2025
015,41930,83846,25761,67620212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 5 buys / 1 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PLX
PROTALIX BIOTHERAPEUTICS, INC.
SALE
168$1.87$3140Nov 18, 2025Nov 19, 2025View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,5007,500Sep 3, 2025Sep 4, 2025View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Sep 3, 2025Sep 4, 2025View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
61,67661,676Sep 29, 2023Oct 3, 2023View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
50,00050,000Sep 7, 2022Sep 9, 2022View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Jan 20, 2020Jan 22, 2020View →
Other insiders · PLX
Loading peer insiders…
About this filer
CIK 0001385113
ROLE
Director
PRIMARY
PLX
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001385113DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback